anti-translocase of outer mitochondrial membrane 22 homolog antibody product blog
Tags: Antibody; Polyclonal Antibody; translocase of outer mitochondrial membrane 22 homolog; anti-translocase of outer mitochondrial membrane 22 homolog antibody;
The translocase of outer mitochondrial membrane 22 homolog n/a (Catalog #MBS713931) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Rabbit anti-human translocase of outer mitochondrial membrane 22 homolog (yeast) polyclonal Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s translocase of outer mitochondrial membrane 22 homolog can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC). Researchers should empirically determine the suitability of the translocase of outer mitochondrial membrane 22 homolog n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Rabbit anti-human translocase of outer mitochondrial membrane 22 homolog (yeast) polyclonal Antibody
Immunogen: Human TOMM22. Storage Buffer: PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20 degree C, Avoid freeze / thaw cycles.
Santa Cruz Alternative: Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-14896 / sc-14894. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing translocase of outer mitochondrial membrane 22 homolog are readily searchable from our website. Different antibodies against the same target such as translocase of outer mitochondrial membrane 22 homolog may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.